The PROOF Centre has granted HTG Molecular Diagnostics exclusive rights to commercialize PROOF Centre-developed gene expression blood tests for the prognosis of patients with Chronic Obstructive Pulmonary Disease (COPD) who will experience frequent exacerbations (“lung attacks”).
The PROOF Centre – …